Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of ALH-L1005 for chronic periodontitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• ALH-L1005

Snippet

Sponsor: AngioLab, Inc. | Conditions: Chronic Periodontitis | Phase 2 | Status: COMPLETED